Pharma Blog Watch

Counterfeit Drugs (Eye on FDA)
In his blog, Mark Senak discusses FDA Associate Commissioner for Policy and Planning Randall Lutter's testimony before the House Subcommittee on Criminal Justice, Drug Policy and Human Resources.